Home>Topics>Companies>Abbott Laboratories

Abbott Laboratories ABT

  1. All
  2. Commentary
  3. Video Reports
  4. Headlines
    1. Global Diabetic Retinopathy Market 2015 - Global Market Size, Trends, Development, and Forecasts to 2019


      Tue, 21 Apr 2015

      Inc. - Regeneron Pharmaceuticals Inc. - Valeant Pharmaceuticals International Inc. Other Prominent Vendors - Abbott Laboratories Ltd. - Alcon Laboratories Inc. - Alimera Sciences Inc. - Allergan Inc. - Ampio Pharmaceuticals Inc. - Antisense

    2. Complexities of Eye Care Drive Strong Moats


      Fri, 6 Mar 2015

      example, Novartis has an estimated 60% market share, yet surgical sales make up only about 6% of total company sales. At Abbott ABT and Valeant, the next-largest players, ophthalmology surgical products account for 5%-7% of total company sales

    3. Global Home Healthcare Market - Industry Analysis, Size, Share, Growth, Trends and Forecast 2014 - 2020


      Fri, 27 Feb 2015

      in the global home healthcare market that have been profiled in the report include 3M Health Care, Bayer AG, Abbott Laboratories , Cardinal Health, Inc., GE Healthcare, Johnson & Johnson Services, Inc., Gentiva Health Services, Inc

    4. Compelling Financial Benefit in Valeant's Latest Buy


      Fri, 27 Feb 2015

      in ophthalmology, since Valeant will face a much more concentrated market and larger competitors, such as Novartis NVS , Abbott ABT , and Johnson & Johnson JNJ , but we still believe there will still be attractive opportunities for Valeant. The market is

    5. Our 2014 Big Pharma Pipeline Rankings: Who Came Out on Top?

      Video Reports

      Fri, 2 Jan 2015

      methodology. If we go back to several years ago when we first started this, firms that ranked very well like [TICKER:ABT] Abbott ( ABT ) and [TICKER:NVS] Novartis (NVS), following two years of their high rankings, they posted 40% gains. A lot of this

      Abbott ABT found at 1:10

      ago when we first started this, firms that ranked very well like [TICKER:ABT] Abbott ( ABT ) and [TICKER:NVS] Novartis (NVS), following two years of their high rankings, they posted 40% gains. A lot of this had to do with
    6. United States Anesthesia Drugs Market & Forecast


      Fri, 12 Dec 2014

      Baxter International Inc, Endo Health Solutions Inc and Abbott Laboratories are three main players, but Others companies also play ..... Market Baxter International Inc Endo Health Solutions Inc Abbott Laboratories AstraZeneca Data Sources This report is built using data and

    7. Top 10 Buys and Sells by the Ultimate Stock-Pickers


      Wed, 3 Sep 2014

      95 39,124 2 Abbott Labs ABT 3 Low Narrow 42.24 ..... of narrow-moat Abbott Laboratories ABT , about which the ..... s position in Abbott Laboratories as the company ..... s stakes in Abbott Laboratories , Stryker, and

    8. A Shift in Health-Care M&A Activity


      Sat, 23 Aug 2014

      issues factor into a company's decision to make an acquisition? And how do you guys incorporate pipeline opportunities? Abbott ABT spinning off AbbVie ABBV comes to mind. Waterhouse : This is an industry where there's not much pricing power, so generally

    9. Abbott Labs Delivers Slightly Better-Than-Expected 2Q


      Wed, 16 Jul 2014

      Abbott posted mixed second-quarter results that on balance slightly exceeded our expectations, but not enough to move the needle on our valuation. However, we do plan to modestly bump up our fair value estimate after incorporating the acquisitions of CFR and Veropharm, along with the divestment of

    10. We Have a Cautious View of Abbott's Planned Purchase of CFR Pharmaceuticals


      Fri, 16 May 2014

      We are somewhat cautious about Abbott Laboratories ' plan to acquire Chile-based CFR Pharmaceuticals, one of the Latin American leaders in branded generic drugs. We are standing

    « Prev12345Next »
    Content Partners